(RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):
-Earnings: -$11.49 million in Q3 vs. -$23.77 million in the same period last year. -EPS: -$0.07 in Q3 vs. -$0.14 in the same period last year. -Analysts projected -$0.11 per share -Revenue: $20.86 million in Q3 vs. $4.87 million in the same period last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
